X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Emma Van Hook

Emma Van Hook Emma Van Hook is a director of Policy & Research at PhRMA focusing on the promise of the biopharmaceutical pipeline, the value of medicines, the R&D process, and personalized medicine. Emma is a biology nerd at heart and has worked in both bench science and in regulatory affairs, helping to get new medicines through the development and FDA approval processes. In her free time, Emma likes to get outside the Beltway for running and hiking with her family and her dog Blue.

Recent Posts

Working together to combat global Zika threat

By Emma Van Hook  |    August 4, 2016
The Zika virus is top of mind as the 2016 Summer Olympic Games get underway tomorrow in Rio. While once thought to be confined to limited areas of Africa, Southeast Asia and the Pacific Islands,...   Read More

New report: Decade of breakthroughs in cancer

By Emma Van Hook  |    June 2, 2016
The pace of science is yielding remarkable innovation for cancer patients as we learn more about the underlying factors driving the spread and growth of cancer. These advances are opening new...   Read More

2015: A banner year for personalized medicine

By Emma Van Hook  |    January 22, 2016
2015 was a record year for personalized medicine approvals, according to a new analysis  from the Personalized Medicine Coalition (PMC). This news confirms the growing role of personalized...   Read More

5 Things You Didn’t Know about Researching and Developing a New Medicine

By Emma Van Hook  |    September 2, 2015
Unless you work in biopharmaceutical research and development (R&D), chances are the process of developing new medicines seems like a black box. It is hard to imagine how researchers go from an...   Read More

ICYMI: New Report on Benefits of Cancer Medicines That Emerge After FDA Approval

By Emma Van Hook  |    July 1, 2015
In case you missed it, Boston Healthcare Associates recently published a report examining how additional benefits of cancer medicines emerge over time through ongoing research after initial...   Read More

ICYMI: The Importance of Enrolling in Clinical Trials

By Emma Van Hook  |    June 26, 2015
Clinical trials are a crucial step in the long and costly process of researching and developing a new medicine to address substantial unmet medical needs in such areas as Alzheimer’s, cancer, and...   Read More

New Chart Pack: Advancing Innovative Treatment Options for Patients Through Personalized Medicine

By Emma Van Hook  |    June 4, 2015
We’re at a remarkable time in medicine, where the rapid pace of science is enabling researchers to make tremendous advances against some of the most devastating diseases. One of the most promising...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates